Answers are grounded in this paper and cite their sources.
Background: Alzheimer’s disease (AD) is the most common neurodegenerative disease characterized with mainly cognitive impairments, and the number of elderly having AD is continuously increasing. Objective: To summarize the pathogenesis of AD and the therapeutic effects of flavonoids on related inflammatory processes. Main ideas: Flavonoids have been shown to alleviate effects of AD both in vitro and in vivo. Conclusion: The clinical significance of these research summaries lay a potential groundwork for the development of new drugs targeting AD treatment.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: